| MolName | (5Z)-5-[[2-[4-(3-chlorophenyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C27H26N5O3ClS2 |
| Smiles | O=C(/C(/S1)=C/C2=C(N(CC3)CCN3c3cccc(Cl)c3)N=C(C=CC=C3)N3C2=O)N(CC2OCCC2)C1=S |
| InChI | InChI=1S/C27H26ClN5O3S2/c28-18-5-3-6-19(15-18)30-10-12-31(13-11-30)24-21(25(34)32-9-2-1-8-23(32)29-24)16-22-26(35)33(27(37)38-22)17-20-7-4-14-36-20/h1-3,5-6,8-9,15-16,20H,4,7,10-14,17H2/t20-/m1/s1 |
| InChIK | MCKVUEBFXRSXNV-HXUWFJFHSA-N |
| TotalMolweight | 568.12 |
| Molweight | 568.12 |
| MonoisotopicMass | 567.116557 |
| CLogP | 2.0107 |
| CLogS | -5.925 |
| H Acceptors | 8 |
| TotalSurfaceArea | 404.26 |
| Relative PSA | 0.26537 |
| PolarSurfaceArea | 126.08 |
| Druglikeness | 5.8662 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.47368 |
| Fragments | 1 |
| Non HAtoms | 38 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| StereoCenters | 1 |
| Rotatable Bond | 5 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 12 |
| Symmetricatoms | 2 |
| Amides | 2 |
| Amines | 1 |
| Aromatic Amines | 1 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[2-[4-(3-chlorophenyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[2-[4-(3-chlorophenyl)piperazin-1-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(oxolan-2-ylmethyl)-2-sulfanylidene-1,3-thiazolidin-4-one